Drug Czar Controversy
By JOHN TIERNEY
Some researchers in substance-abuse treatment and advocates for the medical use of marijuana marijuana are alarmed at reports that Representative Jim Ramstad, a Republican from Minnesota, is a candidate to become the next drug czar — the director of the office of National Drug Control Policy. In a joint letter to President-elect Barack Obama, coordinated by Andrew Tatarsky, the past president of the division of addictions of the New York State Psychological Association, dozens of academics and other professionals in substance-abuse treatment write:
This country needs a drug czar who supports evidence-based policies and one who will make decisions based on science, not politics or ideology. We strongly believe that Congressman Ramstad is not that person.
Rep. Ramstad voted in 1998 in favor of making permanent the federal funding ban on syringe exchange. In 2000, he voted to prohibit the District of Columbia from spending its own locally-raised funds on syringe exchange programs, and in 2007, he voted against lifting the same DC ban, despite decades of research showing that syringe exchange programs reduce the spread of HIV/AIDS, save lives, save money, and do not increase drug use. Representative Ramstad has also consistently opposed congressional efforts to stop the arrest of patients with HIV/AIDS, cancer, and other illnesses who use medical marijuana to ease their pain and suffering in states where it is legal.
http://tierneylab.blogs.nytimes.com/2008/12/08/drug-czar-controversy/edited to make clear that the POS is Ramstad.